U.S. flag

An official website of the United States government

Display Settings:

Items per page
You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 8

1.
Appendix Figure 1.

Appendix Figure 1. From: Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy.

Summary of evidence search and selection.

Sonali Paul, et al. Ann Intern Med. ;164(1):30-40.

CitationFull text

2.
Appendix Figure 4.

Appendix Figure 4. From: Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy.

Absolute risk for HBV reactivation without antiviral prophylaxis in patients with resolved HBV infection.

Sonali Paul, et al. Ann Intern Med. ;164(1):30-40.

CitationFull text

3.
Figure 1.

Figure 1. From: Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy.

Absolute risk for HBV reactivation without antiviral prophylaxis in patients with chronic HBV infection.

Sonali Paul, et al. Ann Intern Med. ;164(1):30-40.

CitationFull text

4.
Appendix Figure 2.

Appendix Figure 2. From: Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy.

Absolute risk for HBV reactivation without antiviral prophylaxis in patients with chronic HBV, by chemotherapy subtype.

Sonali Paul, et al. Ann Intern Med. ;164(1):30-40.

CitationFull text

5.
Figure 3.

Figure 3. From: Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy.

Odds ratio for HBV reactivation with and without antiviral prophylaxis in patients with chronic HBV infection.

Sonali Paul, et al. Ann Intern Med. ;164(1):30-40.

CitationFull text

6.
Figure 2.

Figure 2. From: Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy.

Absolute risk for HBV reactivation without antiviral prophylaxis in patients with chronic HBV infection, by tumor subtype.

Sonali Paul, et al. Ann Intern Med. ;164(1):30-40.

CitationFull text

7.
Figure 4.

Figure 4. From: Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy.

Odds ratio for secondary outcomes with and without antiviral prophylaxis in patients with chronic HBV infection.

Sonali Paul, et al. Ann Intern Med. ;164(1):30-40.

CitationFull text

8.
Appendix Figure 3.

Appendix Figure 3. From: Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy.

Absolute risk for secondary outcomes without antiviral prophylaxis in patients with solid tumors and chronic HBV infection.

Sonali Paul, et al. Ann Intern Med. ;164(1):30-40.

CitationFull text

Display Settings:

Items per page

Supplemental Content

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center